Research work · 2016
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix, Shukui Qin, Philippe Merle
The Lancet
Research work · 2016
Jordi Bruix, Shukui Qin, Philippe Merle
The Lancet